BB&T Securities’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $401K | Buy |
10,928
+1,778
| +19% | +$65.2K | ﹤0.01% | 1185 |
|
|
2019
Q2 | $244K | Sell |
9,150
-2,001
| -18% | -$53.4K | ﹤0.01% | 1412 |
|
|
2019
Q1 | $299K | Buy |
+11,151
| New | +$299K | ﹤0.01% | 1286 |
|
|
2018
Q4 | – | Sell |
-17,049
| Closed | -$353K | – | 1467 |
|
|
2018
Q3 | $353K | Sell |
17,049
-1,569
| -8% | -$32.5K | ﹤0.01% | 1249 |
|
|
2018
Q2 | $284K | Buy |
18,618
+3,613
| +24% | +$55.1K | ﹤0.01% | 1295 |
|
|
2018
Q1 | $337K | Buy |
15,005
+2,347
| +19% | +$52.7K | ﹤0.01% | 1177 |
|
|
2017
Q4 | $381K | Buy |
12,658
+7,295
| +136% | +$220K | ﹤0.01% | 1083 |
|
|
2017
Q3 | $202K | Sell |
5,363
-5,540
| -51% | -$209K | ﹤0.01% | 1277 |
|
|
2017
Q2 | $304K | Buy |
+10,903
| New | +$304K | ﹤0.01% | 1127 |
|